Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-22, Stock:ABT, The news for the past five days is as follows:
2018-03-15: NEWS1: Assessing Pfizer’s 4Q17 Quarterly Revenue Trend.NEWS2: Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns.NEWS3: Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns.NEWS4: Noteworthy ETF Inflows: IHI, ABT, BDX, SYK.NEWS5: Noteworthy ETF Inflows: IHI, ABT, BDX, SYK.NEWS6: Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns.NEWS7: Capitol to Capital: Cramer's 'Mad Money' Recap (Wednesday 3/14/18).
2018-03-16: NEWS1: TMO’s Advanced Laboratory Management System Could Gain Market Share.NEWS2: What Analysts Recommend for Thermo Fisher Scientific.
2018-03-19: NEWS1: HAE Is Expected to Report Flat Revenue Performance in Fiscal 2018.NEWS2: What Investors Should Know about TMO’s Dividends.NEWS3: 5 Dividend Growth Stocks With Upside To Analyst Targets.NEWS4: 5 Dividend Growth Stocks With Upside To Analyst Targets.NEWS5: Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation.NEWS6: See what the IHS Markit Score report has to say about Abbott Laboratories..NEWS7: A Look at TMO’s New High Pressure Ion Chromatography System.
2018-03-20: NEWS1: Goldman Sachs Backs Emerging Markets: MedTech Stocks in Focus.NEWS2: Goldman Sachs Backs Emerging Markets: MedTech Stocks in Focus.NEWS3: Abbott's MitraClip Therapy Wins Reimbursement Nod From MHLW.NEWS4: Abbott's MitraClip Therapy Wins Reimbursement Nod From MHLW.NEWS5: Plasma Remains an Attractive Business for HAE.NEWS6: Abbott&apos;s MitraClip Therapy Wins Reimbursement Nod From MHLW.NEWS7: Plasma Continues to Drive Strong Growth for HAE in Fiscal 2018.NEWS8: What Are Thermo Fisher Scientific’s Current Valuations?.NEWS9: HAE Expects a Modest Net Profit Margin Expansion in Fiscal 2018.NEWS10: How TMO Stock Has Performed Recently.NEWS11: ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch.NEWS12: ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch.
2018-03-21: NEWS1: Abbott Hosts Conference Call for First-Quarter Earnings.NEWS2: See what the IHS Markit Score report has to say about Abbott Laboratories..NEWS3: HAE Is Well Placed to Compete in Plasma Collection in Fiscal 2018.

Answer: Decrease